Leak Confirms OpenAI Is Testing 'ChatGPT for Science' Subscription Tier for Verified Research Institutions

References to a 'ChatGPT for Science' subscription tier appeared in OpenAI's web build on June 17, revealing a planned offering with specialized grounding in scientific discoveries and research topics. Like GPT-Rosalind — available only to select pharmaceutical companies and research institutions — the tier would likely be restricted to verified universities and biotech or pharma organizations rather than general consumers. OpenAI has not commented and no launch date was given, though the feature is being actively tested and an announcement is expected within weeks. The discovery lands the same day OpenAI published its LifeSciBench benchmark, signaling a coordinated push into enterprise life-science markets.